BA
INSY

BlackRock Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

BlackRock Advisors’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.6M Sell
282,128
-59,261
-17% -$670K ﹤0.01% 1398
2016
Q3 		$4.03M Buy
341,389
+61,758
+22% +$939K ﹤0.01% 1192
2016
Q2 		$3.62M Buy
279,631
+25,192
+10% +$367K ﹤0.01% 1233
2016
Q1 		$4.07M Sell
254,439
-43,411
-15% -$824K ﹤0.01% 1175
2015
Q4 		$8.53M Buy
297,850
+282,939
+1,898% +$7.84M 0.01% 909
2015
Q3 		$424K Buy
14,911
+124
+0.8% +$4.56K ﹤0.01% 2301
2015
Q2 		$531K Buy
14,787
+3,637
+33% +$113K ﹤0.01% 2140
2015
Q1 		$324K Buy
11,150
+1,414
+15% +$37.4K ﹤0.01% 2391
2014
Q4 		$205K Sell
9,736
-128,118
-93% -$2.53M ﹤0.01% 2607
2014
Q3 		$2.67M Sell
137,854
-661,472
-83% -$10.4M ﹤0.01% 1101
2014
Q2 		$12.5M Buy
799,326
+511,150
+177% +$8.26M 0.01% 723
2014
Q1 		$5.97M Sell
288,176
-670,018
-70% -$13.3M 0.01% 930
2013
Q4 		$12.4M Sell
958,194
-246,987
-20% -$3.43M 0.01% 724
2013
Q3 		$14.1M Sell
1,205,181
-167,037
-12% -$1.37M 0.01% 674
2013
Q2 		$6.33M Buy
+1,372,218
New +$5.03M 0.01% 898

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's INSY Position: Q4 2016 in Review

BlackRock Advisors reduced its Insys Therapeutics, Inc. (INSY) stake by 17% in Q4 2016, selling an estimated $670K and leaving 282,128 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

BlackRock Advisors first reported a position in INSY in Q2 2013 and has held it in 15 quarters since. The position peaked at $14.1M in Q3 2013. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • BlackRock Advisors held 282,128 shares of Insys Therapeutics, Inc. worth $2.6M as of Q4 2016.
  • BlackRock Advisors sold 59,261 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $670K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1398 holding.
  • BlackRock Advisors first reported a position in Insys Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Insys Therapeutics, Inc. position peaked at $14.1M in Q3 2013.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.